ABA SVP Paul Benda provides an update about the Omicron variant of COVID-19 in the 37th episode of the weekly ABA Pandemic Update podcast. Benda discusses the incredible increase in cases, severity estimates, how vaccines are holding up and boosters for teenagers. Benda also talks about some bright spots for the immunocompromised, and where we go from here.

In the latest episode of the ABA Pandemic Update, Paul Benda focuses on the incredible growth of the omicron variant, what it's doing at home and abroad, how vaccines and other treatments such monoclonal antibodies are holding up, when to use a hard-to-get rapid antigen test, the status of vaccines for 2-5-year-olds and considerations for holiday travel and gatherings.

In the 35th episode of the weekly ABA Pandemic Update podcast, ABA SVP Paul Benda provides an update about the Omicron variant of COVID-19. He discusses current case counts, tracking the Omicron variant, how severe it is and if vaccines will continue to protect us. Benda also talks about early antibody neutralization studies that give an idea about how well vaccines will hold up and if the Pfizer vaccine or Moderna vaccine is better.

In the latest episode of the weekly ABA Pandemic Update podcast, ABA SVP Paul Benda provides an update about the Omicron variant of COVID-19, what is it, what does it mean, what can we do about it and how worried should we be. He also discusses booster shots and a potential timeline for Omicron variant specific booster shots.

In the latest episode of the weekly ABA Pandemic Update podcast, ABA SVP Paul Benda provides an update on continued rise in cases and about booster shot effectiveness, how long they last and how available they are. He also discusses how therapeutics may to the end of the pandemic and a new use case for mRNA vaccines.

In the latest episode of the weekly ABA Pandemic Update podcast, ABA SVP Paul Benda discusses bad news on rising case counts, new data on contagiousness of the Delta variant of COVID-19, vaccination protection timelines, vaccine booster shot and treatment news and an update on the Occupational Safety and Health Administration’s emergency temporary standard.

In the latest episode of the weekly Pandemic Update podcast, ABA SVP Paul Benda discusses new data on recovered immunity, vaccines for children and a new study on Ivermectin. Benda also talks with ABA SVP Jonathan Thessin about the Occupational Safety and Health Administration's emergency temporary standard that will require all employers with 100 or more employees to be fully vaccinated or test weekly for COVID-19.

ABA SVP Paul Benda discusses the FDA review of children vaccines, booster shot data, predictions for the future and the factors that will affect it such as recovered immunity durability. He also talks about the new Delta plus variant and what to know about other “scariants.”

On the latest episode of the ABA Pandemic Update podcast, ABA SVP Paul Benda discusses a recent visit to Universal Studios, current case trends, booster approvals, timelines and mixing and matching, and what does it mean to live with COVID.

On the latest episode of the ABA Pandemic Update podcast, ABA SVP Paul Benda discusses our declining cases, examines how they correspond to other countries’ Delta variant wave as well as the 1918 flu pandemic, compares recovered immunity and vaccinated immunity, looks at booster schedules for Moderna, Johnson and Johnson (as well as approval for children’s vaccines) and touches on vaccine mandates and religious exemptions.